Abivax S.A. (ABVX) Non Operating Income (2024 - 2026)

Abivax (ABVX) has reported Non Operating Income for 3 consecutive years, with $9.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non Operating Income rose 271.99% year-over-year to $9.4 million; the TTM figure through Mar 2026 stood at -$82.9 million (down 649.4% YoY), while the FY2025 annual figure was -$98.0 million, down 2679.42% from the prior year.
• Non Operating Income came in at $9.4 million for Q1 2026 at Abivax, up from -$5.2 million in the prior quarter.
• The five-year high for Non Operating Income was $9.4 million in Q1 2026, with the low at -$84.9 million in Q3 2025.
• Average Non Operating Income over 3 years is -$10.2 million, with a median of -$3.7 million recorded in 2024.
• Across the five-year window, Non Operating Income sank 1435.29% in 2025 and surged 271.99% in 2026, its largest moves.
• Year by year, Non Operating Income stood at $3.6 million in 2024, then tumbled by 243.94% to -$5.2 million in 2025, then jumped by 279.96% to $9.4 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $9.4 million, -$5.2 million, and -$84.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.